Sars-cov-2 virus, inactivated
Highest phase reached
Approved
Drug type
Vaccine component
First approval year
2022
- First approval year
- 2022
- Listing at source
- Listed
- Highest phase reached
- Approved
- Drug type
- Vaccine component
- Drug name
- Sars-cov-2 virus, inactivated
- covid 19 vaccine inactivated adjuvanted valneva
- Covid-19 vaccine (inactivated, adjuvanted) valneva
- sars cov 2 virus inactivated
- Sars-cov-2 virus, inactivated
- ChEMBL ID
- CHEMBL6068383
- First in class
- No
- Orphan designation
- No
- Drug name stem
- vir-
- Condition
- Vaccination
- Highest recorded phase
- 4
- Condition identifier
- EFO:0004292
- Subject identifier
- D014611
- Condition
- COVID-19
- Highest recorded phase
- 4
- Condition identifier
- MONDO:0100096
- Subject identifier
- D000086382
- Condition identifier
- MONDO_0100096
- Condition identifier
- MONDO_0100096
- Highest recorded phase
- 4
- Prodrug
- No
- Chirality
- Single enantiomer
- Inorganic
- No
- Natural product
- No
Related records
Trials (15)
- A Clinical Trial on Sequential Immunization of Recombinant COVID-19 Vaccine (CHO Cell, NVSI-06-09) and Inactivated COVID-19 Vaccine (Vero Cell)
- A Study to Assess the Safety and Immunogenicity of the Coronavac Vaccine Against COVID-19
- Active Pharmacovigilance Study of Adsorbed COVID-19 (Inactivated) Vaccine
- Adverse Events Report of Inactivated COVID-19 Vaccine
- An Effectiveness Study of the Sinovac's Adsorbed COVID-19 (Inactivated) Vaccine
- Clinical Trial of Efficacy and Safety of Sinovac's Adsorbed COVID-19 (Inactivated) Vaccine in Healthcare Professionals
- Clinical Trial on Sequential Immunization of Recombinant COVID-19 Vaccine (CHO Cells,NVSI-06-08) and Inactivated COVID-19 Vaccine (Vero Cells) in Population Aged 18 Years and Above
- Immunogenicity and Safety Study of SCB-2019 Vaccine as a Booster to COVID-19 Vaccine in Adults
- Immunogenicity and Safety Study of the 3rd Booster Dose Using the High or Medium Dose of Inactivated (CoronaVac®) Vaccine in Healthy Adults in Turkey
- Oxidative Stress Parameters, Trace Element and Quality of Life in Men Before and After Covid-19 Vaccines
- Oxidative Stress Parameters, Trace Element and Quality of Life in Women Before and After Covid-19 Vaccines
- Reactogenicity, Safety and Immunogenicity of QazCovid-in® COVID-19 Vaccine
- Serological Response to mRNA and Inactivated COVID-19 Vaccine in Health Care Workers in Hong Kong
- UNAIR Inactivated COVID-19 Vaccine
- UNAIR Inactivated COVID-19 Vaccine as Heterologue Booster (Immunobridging Study)